Congressional portrait of Alex Padilla
Portrait provenance: congressional member image keyed to Bioguide ID P000145. Official Congressional Pictorial Directory context ↗

U.S. Senate · researched profile

Alex Padilla

Ranking Member — Senate Committee on Rules and Administration

DemocraticBioguide P000145

Alex Padilla is a Democratic senator from California who has served in the Senate since 2021, according to Congress.gov.

Profile updated Aug 17, 2026

Editorial public-record review

Profile research reviewed Aug 17, 2026

Alex Padilla is a Democratic senator from California who has served in the Senate since 2021, according to Congress.gov.

Open biography & office record ↓
Biography & Current Office

Alex Padilla

Alex Padilla is a Democratic senator from California who has served in the Senate since 2021, according to Congress.gov.

The Senate Committee on Rules and Administration lists Padilla as its ranking member, serving opposite Chairman Mitch McConnell. The committee has jurisdiction over Senate administration and a range of federal-election and congressional matters.

On February 11, 2026, Padilla introduced S. 3840, a proposal to designate Health Investment Zones in areas with large health disparities. Congress.gov records the bill as referred to the Senate Finance Committee and still at the introduced stage.

Current / reviewed roles

  • Ranking Member — Senate Committee on Rules and Administration
  • U.S. Senator — California
Committees & Leadership

Current and reviewed institutional roles

  • Senate Committee on Rules and Administration — Ranking Member
Curated Notable Legislation

Legislation & congressional activity

S. 3840 — Health Investment Zones Act of 2026

Padilla introduced S. 3840 on February 11, 2026; Congress.gov records it as referred to the Senate Finance Committee and at the introduced stage.

Claims & Evidence

Evidence tracker

NOT RATEDNo automatic rating is assigned merely because this person holds office. Sourced claim reviews appear here when a specific, fact-checkable statement warrants one.